Cosmo Pharmaceuticals N.V. | Cash Flow
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
88,212.00
132,171.70
271,520.00
29,959.40
36,005.50
20,157.80
Depreciation, Depletion & Amortization
10,930.70
10,641.60
9,062.10
3,313.00
3,930.00
5,177.10
Other Funds
-
-
-
-
192.10
10,459.30
Funds from Operations
16,890.10
66,532.10
25,364.60
36,129.80
5,744.10
4,521.30
Changes in Working Capital
6,904.70
14,150.80
16,519.30
7,348.40
1,050.20
3,989.10
Net Operating Cash Flow
9,985.40
80,682.90
41,883.90
28,781.30
6,794.30
8,510.40
Capital Expenditures
3,139.70
3,041.70
2,708.90
20,080.40
24,462.90
Sale of Fixed Assets & Businesses
-
49.80
119,101.90
26.20
40.00
Purchase/Sale of Investments
587.10
10,999.80
32,196.10
63,891.00
4,660.50
Net Investing Cash Flow
3,945.90
13,997.80
84,282.40
43,836.70
29,083.50
Cash Dividends Paid - Total
-
17,309.10
-
21,517.90
25,041.30
Issuance/Reduction of Debt, Net
1,380.90
896.10
3,016.40
-
-
Net Financing Cash Flow
17,389.80
81,498.90
2,744.10
24,610.70
80,677.00
Net Change in Cash
23,429.30
14,813.80
39,654.40
50,536.80
30,302.50
Free Cash Flow
7,579.20
78,011.60
43,921.10
26,783.70
20,437.40
Other Sources
-
-
85.40
-
-
Change in Capital Stock
18,770.80
63,293.70
272.30
-
106,858.50
Exchange Rate Effect
-
-
-
2,529.40
14,496.80
Other Uses
219.10
6.10
-
-
-
About Cosmo Pharmaceuticals
View Profile
